» Articles » PMID: 1469086

O-linked Carbohydrate of Recombinant Von Willebrand Factor Influences Ristocetin-induced Binding to Platelet Glycoprotein 1b

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1992 Dec 1
PMID 1469086
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

By transfecting the full-length cDNA for human von Willebrand factor (vWf) into a line of Chinese hamster ovary cells with a defect in carbohydrate metabolism, we have prepared recombinant vWf specifically lacking O-linked carbohydrates. We have compared this under-glycosylated protein to fully glycosylated recombinant vWf with respect to several structural and binding properties. vWf deficient in O-linked glycans was synthesized, assembled into multimers, and secreted in an apparently normal manner and was not prone to degradation in the extracellular milieu. It did not differ from fully glycosylated vWf in ability to bind to heparin or to collagen type I but did interact less well with glycoprotein 1b on formalin-fixed platelets. This decreased interaction was evidenced in both a lessened overall binding to platelets and in diminished capacity to promote platelet agglutination, in the presence of ristocetin. In contrast, no difference was seen in platelet binding in the presence of botrocetin. These data indicate a possible role for O-linked carbohydrates in the vWf-glycoprotein 1b interaction promoted by ristocetin and suggest that abnormalities in carbohydrate modification might contribute to the altered ristocetin-dependent reactivity between vWf and platelets described for some variant forms of von Willebrand disease.

Citing Articles

O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies.

Karampini E, Doherty D, Burgisser P, Garre M, Schoen I, Elliott S Blood Adv. 2024; 8(12):3254-3266.

PMID: 38640438 PMC: 11226974. DOI: 10.1182/bloodadvances.2023012499.


Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.

Kardeby C, Falker K, Haining E, Criel M, Lindkvist M, Barroso R Blood Adv. 2019; 3(3):275-287.

PMID: 30700416 PMC: 6373755. DOI: 10.1182/bloodadvances.2018024950.


Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus.

Li L, Qu C, Wu X, Dai J, Lu Y, Gong Y J Thromb Thrombolysis. 2017; 45(1):56-65.

PMID: 29032524 DOI: 10.1007/s11239-017-1573-2.


Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects.

Song J, Chen F, Campos M, Bolgiano D, Houck K, Chambless L PLoS One. 2015; 10(8):e0132626.

PMID: 26244499 PMC: 4526567. DOI: 10.1371/journal.pone.0132626.


von Willebrand factor, Jedi knight of the bloodstream.

Springer T Blood. 2014; 124(9):1412-25.

PMID: 24928861 PMC: 4148764. DOI: 10.1182/blood-2014-05-378638.


References
1.
Debeire P, Montreuil J, Samor B, Mazurier C, GOUDEMAND M, van Halbeek H . Structure determination of the major asparagine-linked sugar chain of human factor VIII--von Willebrand factor. FEBS Lett. 1983; 151(1):22-6. DOI: 10.1016/0014-5793(83)80334-2. View

2.
Southern P, Berg P . Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet. 1982; 1(4):327-41. View

3.
Ruggeri Z, Pareti F, Mannucci P, Ciavarella N, ZIMMERMAN T . Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med. 1980; 302(19):1047-51. DOI: 10.1056/NEJM198005083021902. View

4.
Jenkins C, Phillips D, Clemetson K, Meyer D, LARRIEU M, LUSCHER E . Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest. 1976; 57(1):112-24. PMC: 436631. DOI: 10.1172/JCI108251. View

5.
Lyons S, Bruck M, BOWIE E, Ginsburg D . Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem. 1992; 267(7):4424-30. View